← Leaderboards
Lily Wu
University Of California Los Angeles
$3,586,954
Attributed
$3,586,954
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $473K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,586,954 · 3
By mechanism
R01$2,879,675 · 1
R21$707,279 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Jay R. Lieberman$6,899,796
- David B Agus$6,707,253
- Gerald S Lipshutz$7,859,338
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisGenesMalignant NeoplasmsIn VivoTumorNeoplastic CellBaseMetastatic Prostate CancerVectorGene ExpressionProstateProstatic NeoplasmsMetastatic ProcessStagingImageAdenovirus VectorGene TherapyMalignant Neoplasm Of ProstateCellsPromotor (Genetics)Cancer CellCytotoxic ChemotherapySerumLymphatic
Grant awards (16)
Explore Epithelial Mesenchymal Transition (EMT) in a Cooperative Model of Metastasis in Renal Cell Carcinoma$164,560
R21 · FY2019 · CA · contact PI
Explore Epithelial Mesenchymal Transition (EMT) in a Cooperative Model of Metastasis in Renal Cell Carcinoma$202,819
R21 · FY2018 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$278,968
R01 · FY2012 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$278,968
R01 · FY2011 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$56,040
R01 · FY2011 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$287,595
R01 · FY2010 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$57,189
R01 · FY2010 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$287,595
R01 · FY2009 · CA · contact PI
Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer$287,595
R01 · FY2008 · CA · contact PI
PET-guided Intervention in Lymphatic Metastasis of Prostate Cancer$185,400
R21 · FY2008 · CA · contact PI
Gene-Based Imaging and Therapy To Target Prostate Cancer$260,759
R01 · FY2007 · CA · contact PI
PET-guided Intervention in Lymphatic Metastasis of Prostate Cancer$154,500
R21 · FY2007 · CA · contact PI
Gene-Based Imaging and Therapy To Target Prostate Cancer$268,547
R01 · FY2006 · CA · contact PI
Gene-Based Imaging and Therapy To Target Prostate Cancer$275,010
R01 · FY2005 · CA
Gene-Based Imaging and Therapy To Target Prostate Cancer$273,230
R01 · FY2004 · CA
Gene-Based Imaging and Therapy To Target Prostate Cancer$268,179
R01 · FY2003 · CA